Bijal D. Shah, MD, on What ALL Tells Us About CAR T Cells

NCCN 2018 Annual Conference
Tweet this page

Bijal D. Shah, MD, of the H. Lee Moffitt Cancer Center, discusses key studies of CAR T-cell therapy in relapsed B-cell ALL and the adverse events that this treatment may cause.

Advertisement

Advertisement



Advertisement